title: Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus.
abstract: Nonstructural protein 3 (NS3) of hepatitis C virus (HCV), codes for protease and helicase carrying NTPase enzymatic activities, plays a crucial role in viral replication and an ideal target for diagnosis, antiviral therapy and vaccine development. In this study, monoclonal antibodies (mAbs) to NS3 helicase were characterized by epitope mapping and biological function test. A total of 29 monoclonal antibodies were produced to the truncated NS3 helicase of HCV-1b (T1b-rNS3, aa1192-1459). Six mAbs recognized 8/29 16mer peptides, which contributed to identify 5 linear and 1 discontinuous putative epitope sequences. Seven mAbs reacted with HCV-2a JFH-1 infected Huh-7.5.1 cells by immunofluorescent staining, of which 2E12 and 3E5 strongly bound to the exposed linear epitope (1231)PTGSGKSTK(1239) (EP05) or core motif (1373)IPFYGKAI(1380) (EP21), respectively. Five other mAbs recognized semi-conformational or conformational epitopes of HCV helicase. MAb 2E12 binds to epitope EP05 at the ATP binding site of motif I in domain 1, while mAb 3E5 reacts with epitope EP21 close to helicase nucleotide binding region of domain 2. Epitope EP05 is totally conserved and EP21 highly conserved across HCV genotypes. These two epitope peptides reacted strongly with 59-79% chronic and weakly with 30-58% resolved HCV infected blood donors, suggesting that these epitopes were dominant in HCV infection. MAb 2E12 inhibited 50% of unwinding activity of NS3 helicase in vitro. Novel monoclonal antibodies recognize highly conserved epitopes at crucial functional sites within NS3 helicase, which may become important antibodies for diagnosis and antiviral therapy in chronic HCV infection.
authors.affiliation: Department of Transfusion Medicine, Southern Medical University, Guangzhou, China.
authors.forename: Yixin
authors.initials: Y
authors.lastname: Bian
authors.forename: Shuoxian
authors.initials: S
authors.lastname: Zhao
authors.forename: Shaomei
authors.initials: S
authors.lastname: Zhu
authors.forename: Jinfeng
authors.initials: J
authors.lastname: Zeng
authors.forename: Tingting
authors.initials: T
authors.lastname: Li
authors.forename: Yongshui
authors.initials: Y
authors.lastname: Fu
authors.forename: Yuanzhan
authors.initials: Y
authors.lastname: Wang
authors.forename: Xin
authors.initials: X
authors.lastname: Zheng
authors.forename: Ling
authors.initials: L
authors.lastname: Zhang
authors.forename: Wenjing
authors.initials: W
authors.lastname: Wang
authors.forename: Baocheng
authors.initials: B
authors.lastname: Yang
authors.forename: Yuanping
authors.initials: Y
authors.lastname: Zhou
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Allain
authors.forename: Chengyao
authors.initials: C
authors.lastname: Li
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology*; D000939:Epitopes / Q000276:immunology*; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000276:immunology*; D018937:Hepatitis C Antibodies / Q000276:immunology*; D017361:Viral Nonstructural Proteins / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000939:Epitopes; D018937:Hepatitis C Antibodies; D017361:Viral Nonstructural Proteins
references.citation: Lancet. 1991 Feb 9;337(8737):317-9
references.pmid: 1671231
references.citation: Microbes Infect. 2002 Oct;4(12):1219-25
references.pmid: 12467763
references.citation: J Virol. 2000 Oct;74(20):9732-7
references.pmid: 11000246
references.citation: Nephrol Dial Transplant. 2009 Sep;24(9):2745-51
references.pmid: 19377056
references.citation: J Virol. 1993 Oct;67(10):6152-8
references.pmid: 8396675
references.citation: J Virol. 2001 Dec;75(24):12412-20
references.pmid: 11711631
references.citation: Biochem Biophys Res Commun. 2010 Feb 26;393(1):131-6
references.pmid: 20117090
references.citation: Virology. 1995 Jan 10;206(1):666-72
references.pmid: 7530398
references.citation: Virol J. 2010 Jun 07;7:118
references.pmid: 20529250
references.citation: Hepatology. 2009 Sep;50(3):707-16
references.pmid: 19637188
references.citation: J Virol. 1999 Oct;73(10):8798-807
references.pmid: 10482634
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8381-7
references.pmid: 11459979
references.citation: EMBO J. 1982;1(8):945-51
references.pmid: 6329717
references.citation: Clin Diagn Lab Immunol. 2000 Jan;7(1):58-63
references.pmid: 10618278
references.citation: Hepatology. 1998 Jul;28(1):219-24
references.pmid: 9657115
references.citation: Curr Issues Mol Biol. 2007 Jan;9(1):1-20
references.pmid: 17263143
references.citation: J Biol Chem. 2003 Nov 7;278(45):44514-24
references.pmid: 12944414
references.citation: J Med Virol. 2004 Mar;72(3):385-95
references.pmid: 14748062
references.citation: Virology. 1999 Sep 30;262(2):470-8
references.pmid: 10502525
references.citation: Top Antivir Med. 2011 Aug-Sep;19(3):117-20
references.pmid: 21946389
references.citation: Am J Pathol. 2004 Oct;165(4):1163-73
references.pmid: 15466383
references.citation: J Hepatol. 2002 Nov;37(5):660-8
references.pmid: 12399234
references.citation: J Virol. 2009 Feb;83(3):1312-9
references.pmid: 19019968
references.citation: J Virol. 1994 Aug;68(8):4829-36
references.pmid: 7518528
references.citation: Hepatology. 1992 Aug;16(2):306-11
references.pmid: 1379209
references.citation: J Biol Chem. 2010 Jul 23;285(30):22725-31
references.pmid: 20457607
references.citation: Biochem Biophys Res Commun. 2011 Nov 25;415(3):503-8
references.pmid: 22062549
references.citation: PLoS One. 2012;7(8):e42455
references.pmid: 22916129